ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States

Go back to ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
(NASDAQ: IBRX) Delayed: 7.10 -0.1 (1.39%)
Previous Close $7.20    52 Week High
Open $7.24    52 Week Low
Day High $7.32    P/E N/A 
Day Low $7.04    EPS
Volume 8,801,324